Scarica l'app Stockscreener
3.44
1.15%
-0.04
Dopo l'orario di chiusura:
3.41
-0.03
-0.87%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SANA Giù?
Forum
Previsione
Sana Biotechnology Inc Borsa (SANA) Ultime notizie
Sana Biotech rises as Mayo Clinic partners for diabetes therapy - MSN
Citizens reiterates Sana Biotechnology stock rating on Mayo deal By Investing.com - Investing.com Canada
Sana Biotechnology Inc. (SANA) hits new milestone on cell therapy for type 1 diabetes - MSN
Seattle InnoCajal raises $96M I Layoffs at Sana - The Business Journals
Sana Biotechnology: Mayo Clinic Deal A Positive Step On A Long Journey (NASDAQ:SANA) - Seeking Alpha
Reloading Alert: PRSO, SANA, ROLR, PMNT – Catalysts Align as Momentum Builds - FinancialContent
SANA Stock Jumps As Mayo Clinic Backs Diabetes Cell Therapy - StocksToTrade
H.C. Wainwright reiterates Sana Biotechnology stock rating at buy By Investing.com - Investing.com Canada
Sana Biotech rises after Mayo Clinic deal (SANA:NASDAQ) - Seeking Alpha
Sana Biotechnology Inc. (SANA) Hits New Milestone on Cell Therapy for Type 1 Diabetes - Insider Monkey
Stock Market Today: Dow Jones, S&P 500 Futures Rise As JD Vance Touts 'Good Deal' If Iran Meets US 'Red Lines'—Sana, Chevron In Focus - Benzinga
Sana Biotechnology Announces Stock Purchase Agreement With Mayo Clinic for 7.5 Million Shares - Minichart
Citigroup, JPMorgan And 3 Stocks To Watch Heading Into Tuesday - Benzinga
Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451 - Bitget
Sana VitaHoney Redefines Everyday Wellness with Portable Honey Spoon Innovation - openPR.com
Sana Biotechnology partners with Mayo Clinic on diabetes therapy By Investing.com - Investing.com India
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Sana Biotechnology IncSells 7.5 Million Shares To Mayo Clinic At $3.33 Per Share For $25 MillionSEC Filing - TradingView — Track All Markets
Sana Biotechnology and Mayo Clinic announce strategic collaboration focused on improving care in type 1 diabetes and accelerating development of SC451 - marketscreener.com
According to the latest disclosure filed with the US Securities and Exchange Commission, the biotechnology company Sana Biotechnology, Inc. has completed a significant equity transaction. - Bitget
Sana Biotechnology Secures Strategic Equity Investment from Mayo - TipRanks
Sana Biotechnology shares gain on Mayo Clinic partnership By Investing.com - Investing.com Canada
Sana Biotechnology partners with Mayo Clinic on diabetes therapy - Investing.com
SANA Stock Rallies 24% After Hours — How Much Is Mayo Clinic Investing In The Company? - Stocktwits
Setup Watch: Is Sana Biotechnology Inc benefiting from interest rate changesWeekly Profit Recap & Capital Efficient Trading Techniques - baoquankhu1.vn
Merger Talk: Can Sana Biotechnology Inc maintain its current growth rateMarket Risk Report & Capital Protection Trade Alerts - baoquankhu1.vn
Sana Biotechnology Stock Short Interest Rises to 46.21% - Moomoo
Director at Sana Biotechnology (SANA) granted 7,763 fully vested RSUs - Stock Titan
Why Smart Money Is Shifting From Clinical Data to Manufacturing Lines - Sahm
Earnings Miss: Is Sana Biotechnology Inc in a long term uptrendWeekly Investment Recap & Fast Moving Stock Trade Plans - baoquankhu1.vn
InvestingPro’s Fair Value spotted Sana Biotech overvaluation early By Investing.com - Investing.com Australia
Growth Recap: What are Sana Biotechnology Incs earnings expectationsMarket Volume Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
SANA Forecast, Price Target & Analyst Ratings | SANA BIOTECHNOLOGY INC (NASDAQ:SANA) - ChartMill
SANA PE Ratio & Valuation, Is SANA Overvalued - Intellectia AI
JPMorgan Chase & Co. Raises Holdings in Sana Biotechnology, Inc. $SANA - MarketBeat
Sana Biotechnology Inc. (SANA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Citi Maintained a Buy Rating on Sana Biotechnology (SANA) - MSN
Sana Biotech Stock Jumps A Whopping 35% After Eric Jackson Calls It ‘Next 100-Bagger Platform’ - MSN
Options Flow: Is Sana Biotechnology Inc a stock for growth or value investorsQuarterly Trade Summary & Expert Approved Momentum Ideas - baoquankhu1.vn
Aug Breakouts: How does Sana Biotechnology Inc score in quality rankingsQuarterly Profit Report & Safe Entry Trade Reports - baoquankhu1.vn
Sana Biotechnology (NASDAQ: SANA) EVP files initial ownership report - Stock Titan
Sana Biotechnology (NASDAQ:SANA) Trading Down 7.2%Here's What Happened - MarketBeat
Shorts Report: How does Sana Biotechnology Inc score in quality rankingsMarket Sentiment Review & Accurate Intraday Trade Tips - baoquankhu1.vn
Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
SANA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Sana Biotechnology (SANA) appoints industry veteran Brian Piper as new CFO - MSN
Bull Run: Will Sana Biotechnology Inc stock hit new highs in YEAR2026 Outlook & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Breakouts Watch: Can Sana Biotechnology Inc be the next market leaderDay Trade & High Accuracy Buy Signal Tips - baoquankhu1.vn
H.C. Wainwright reiterates Sana Biotechnology stock buy rating - Investing.com
Sana Biotechnology reports 14-month data on diabetes cell therapy By Investing.com - Investing.com India
Integral Health Asset Management LLC Has $7.10 Million Stock Position in Sana Biotechnology, Inc. $SANA - MarketBeat
Morgan Stanley Maintains Overweight on Sana Biotechnology, Inc. (SANA) March 2026 - Meyka
Morgan Stanley reiterates Sana Biotechnology stock rating on diabetes data By Investing.com - Investing.com Canada
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):